Search Results - Danny M. Cohn, MD, PhD
- Showing 1 - 2 results of 2
-
1
Daratumumab-based treatment of monoclonal gammopathy–associated angioedema due to acquired C1-inhibitor deficiency by Remy S. Petersen, MD, Lauré M. Fijen, MD, PhD, Laurens E. Franssen, MD, PhD, Josephine M.I. Vos, MD, PhD, Danny M. Cohn, MD, PhD
Published in Journal of Allergy and Clinical Immunology: Global (2024-11-01)Get full text
Article -
2
Global frequency, diagnosis, and treatment of hereditary angioedema with normal C1 inhibitor by Markus Magerl, MD, Marc A. Riedl, MD, MS, Luisa Karla Arruda, MD, PhD, Andrea Bauer, MD, MPH, Alejandro Berardi, MD, Jonathan A. Bernstein, MD, Laurence Bouillet, MD, PhD, Matthew Buckland, PhD, Thomas Buttgereit, MD, Danny M. Cohn, MD, PhD, Timothy Craig, DO, Roberta F. Criado, MD, PhD, Aurélie Du-Thanh, MD, PhD, Olivier Fain, MD, Margarida Gonçalo, MD, PhD, Jens Greve, MD, Anete Sevciovic Grumach, MD, PhD, Mar Guilarte, MD, PhD, Constance Katelaris, MD, PhD, Tamar Kinaciyan, MD, Elena A. Latysheva, MD, Ramon Lleonart, MD, Oscar Calderón Llosa, MD, Eli Mansour, MD, PhD, Vesna Grivcheva-Panovska, MD, PhD, Claudio Parisi, MD, Nelson Augusto Rosario Filho, MD, PhD, Amélia Spínola Santos, MD, Petra Staubach, MD, Anna Valerieva, MD, PhD, Solange Oliveira Rodrigues Valle, MD, PhD, Sherry Danese, MBA, Julie Ulloa, Paul K. Audhya, MD, MBA, Marcus Maurer, MD
Published in Journal of Allergy and Clinical Immunology: Global (2025-08-01)Get full text
Article
